SANOFI SYNTHELABO SA 13D and 13G filings for LAVA Therapeutics N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-31 11:19 am Purchase |
2021-03-25 | 13G | LAVA Therapeutics N.V. LVTX |
SANOFI SYNTHELABO SA | 1,919,455 7.000% |
1,919,455 (New Position) |
Filing |